glp-1 after bariatric surgery Weighted percent weight loss over time following and Bariatric Surgery vs. GLP-1 Drugs

This landmark study evaluated the efficacy of semaglutide (Wegovy) and found it delivered significantly greater weight reduction than liraglutide (Saxenda) 15% mean weight loss over 68 weeks

Published case reports and expert consensus from gastroenterology societies indicate that patients with resolved diverticulitis and no ongoing inflammation tolerate semaglutide well in follow-up studies

Lean Mass Preservation: The Non-Negotiable Preserve Phase Lean mass preservation is essential during midlife GLP-1 therapy because estrogen decline already accelerates muscle loss

doi: 10.14814/phy2.13994 40 MannJ

While some users may notice appetite changes within the first few weeks of taking Advanced BioNutritionals GLP-1 Plus, significant body composition changes typically occur over months rather than weeks